04.06.2012

Europharm Brasov, the drug plant of UK giant GlaxoSmithKline, ended last year with turnover of around EUR100 million, up by around 10% on 2010. more

03.19.2012

The Romanian Competition Council said Monday it slapped several pharmaceutical companies with fines worth a total EUR12 million for sealing anti-competition agreements. more

03.15.2012

The number of boxes of medicine produced in Romania has dropped by 40% in the last five years, from 315 million in 2006 to 190 million in 2011, because the authorities "have sabotaged the domestic more

02.10.2012

The Romanian pharmaceutical market reached EUR2.55 billion in 2011, up 11.5% on the year, according to market research company Cegedim. Sales of drugs rose by almost 30% in the fourth quarter of 2011, more

01.06.2012

The Romanian pharmaceutical market might return to double-digit growth this year, after a 7% increase to approximately EUR2.56 billion in 2011, according to ZF estimates based on data provided by more

12.28.2011

Drug sales in Romania could exceed EUR2.4 billion this year, up 6.4% on the year, according to ZF estimates based on data from market research company Cegedim. more

11.18.2011

Jacques Nathan, the new country manager of Sanofi Romania, says the factory in Bucharest has a strategic importance in the group and will be used to produce and launch new drugs, while the group is more

11.15.2011

Pharmaceutical company GlaxoSmithKline (GSK), which owns drug maker Europharm in Brasov (central Romania), expects to sell 75% of its output abroad next year, compared with 60% this year and 43% in more

11.11.2011

Drug sales leaped significantly in the third quarter of the year, rising by nearly 14% in value against the similar period of 2010, to 2.74 billion lei (EUR643 million), according to data from market more

10.17.2011

Stephen Stead, chief executive officer of pharmaceutical company Labormed, controlled by investment fund Advent International, says that things are extremely volatile on the drug market and although more

08.25.2011

The ten largest drug makers with plants on the Romanian market last year generated cumulated turnover of more than EUR450 million, almost 20% higher than in 2009, shows a ZF analysis based on Finance more

08.24.2011

German-held drug producer Boehringer Ingelheim appointed physician Jan Stefan Scheld at the helm of its Romanian unit, effective September 1. more

06.14.2011

Ropharma (RPH.RO) forecasts a turnover of 400 million lei (EUR96 million) for this year, up 14% from 2010, a figure that will bring its indirect owner, local businessman Mihai Miron, amongst the top more

05.26.2011

Swiss drug maker Sandoz recently appointed Adrian Samson as country head, replacing Iztok Sever, who "chose to pursue personal projects outside the company". more

05.11.2011

The growth of Romania’s pharmaceutical market slowed in the first quarter to just 2.8%, from 4.4% in the final quarter of 2010, market research firm Cegedim said Wednesday. more

05.09.2011

Four companies in the drug industry, GlaxoSmithKline (GSK), Eli Lilly, Farmexpert and MSD, have changed their management this year, which could amount to the start of a new wave of departures in the more

05.05.2011

The Romanian pharmaceutical has slowed its growth in the first quarter this year, rising 5.6% on the year, to EUR637 million, helped by over-the-counter and retail sales, according to market research more